By Sahithya K · Reviewed by Divya Chandradhara · Published 4 November 2026

CTRI registration is the entry of a clinical study in the Clinical Trials Registry – India, the free, searchable public registry for studies conducted in India. Registration must be completed before the first participant is enrolled. A trial that starts enrolment first cannot be registered at all, because the CTRI has accepted only prospective registration since 1 April 2018.

What the Clinical Trials Registry – India (CTRI) is

The Clinical Trials Registry – India, or CTRI, is an online, free and searchable system for the prospective registration of clinical studies conducted in India. It is a Primary Registry in the World Health Organization’s registry network, so trials registered there are also visible through the WHO search portal. The registry was launched on 20 July 2007 and is hosted by the ICMR-National Institute for Research in Digital Health.

The CTRI also registers studies conducted in countries that have no Primary Registry of their own. It captures details specific to the Indian arm of a trial, such as sites, principal investigators, the ethics committee and its approval status, the target sample size in India and the start date in India.

Which studies need CTRI registration

Registration of every regulatory clinical trial is mandatory. Rule 25(v) of the New Drugs and Clinical Trials Rules, 2019 makes it a condition of every clinical trial permission that the trial is registered with the registry, which the Rules name the Clinical Trial Registry of India, maintained by the Indian Council of Medical Research, before the first subject is enrolled. The same condition applies to bioavailability and bioequivalence studies.

The CTRI registers all types of clinical study: interventional studies, observational studies, post-marketing studies and bioavailability and bioequivalence studies. It also registers studies from traditional systems of medicine and studies conducted as part of a postgraduate thesis. Ethics committees, medical colleges and journal editors require registration for many studies that the Rules do not cover, and the registry repeats the WHO’s advice for uncertain cases: when in doubt, register.

Who is responsible for CTRI registration: sponsor or investigator

The registrant is either the principal investigator or the primary sponsor, decided by agreement between them. The CTRI states that the primary sponsor is ultimately accountable for making sure the trial is properly registered. For multi-centre and multi-sponsor trials, the lead principal investigator or the lead sponsor takes responsibility.

A company trial should be registered under the company’s name, not under an employee’s individual account. The CTRI asks for this so that a trial does not have to be transferred between accounts when an employee leaves the organisation.

When to register a trial on the CTRI

A clinical study must be registered before the first participant is enrolled. Since 1 April 2018 the CTRI registers studies only prospectively, and the CTRI FAQ is explicit on the consequences:

  • A trial that began enrolment before receiving a CTRI number cannot be registered, even if a reference (REF) number had already been issued.

  • A trial uploaded before enrolment but started before registration was completed cannot be registered afterwards.

  • A retrospective data collection study must be registered before data collection begins.

For a sponsor, the practical effect is that CTRI registration belongs in the start-up plan alongside ethics committee approval and regulatory permission, not after them as an administrative step.

How CTRI registration works, step by step

Registration is a sequence of online steps, and nothing is submitted on paper.

  1. The registrant creates a user account on ctri.nic.in using the new user form. The account is activated after a second confirmation email.

  2. The registrant adds a new trial and completes the online dataset, which can be filled in parts.

  3. The registrant uploads the ethics committee approval and, where applicable, the approval of the Drugs Controller General (India). Both uploads are mandatory.

  4. The registrant submits the trial. If every mandatory field is complete, a REF number is assigned immediately.

  5. The CTRI reviews the submission within 10 working days and returns it for clarification or modification.

  6. The CTRI emails the trial’s designated contacts, including the overall principal investigator, the scientific and public query contacts and each site principal investigator, who must confirm their participation.

  7. The registrant resubmits with the changes made, approvals uploaded and verifications received. A CTRI number is assigned once the registry is satisfied.

The speed of the process depends mostly on the registrant. Further action can only be taken once the trial is resubmitted, so the sooner modifications, uploads and verifications are complete, the sooner the trial is registered. Regulatory support at start-up often covers the CTRI dataset alongside the ethics and regulatory submissions.

REF number vs CTRI number

A REF number is a reference for a submitted trial. A CTRI number means the trial is registered. Only the CTRI number allows enrolment to begin, and the FAQ states plainly that a trial holding only a REF number is not registered.

The CTRI issues no registration certificate. The CTRI number is quoted wherever proof is needed, and a PDF of the registered record can be generated from the public listing. The record appears in the public domain as soon as the trial is registered.

CTRI registration for trials already on another registry

A trial conducted in India must be registered with the CTRI even if it is already registered in another Primary Registry or in ClinicalTrials.gov. The CTRI record carries the information specific to the Indian arm. To keep the two records identified as a single trial, the registrant quotes the other registry’s number in the Secondary ID section of the CTRI record.

Changing a registered CTRI record

A registered trial cannot be deleted from the CTRI, and suspended trials follow the same rule. Changes such as new sites, new principal investigators or new contact persons are made under the CTRI’s change procedure, by email to the registry quoting the REF number. Sites that have not yet received ethics committee approval are confirmed by their principal investigator in the same way.

Registration is also part of the wider transparency expected of trials. ICH E6(R3), the current ICH good clinical practice guideline, lists timely registration on publicly accessible and recognised databases, and public posting of results, among its principles.

Questions about CTRI registration

Is CTRI registration mandatory?

Yes, for every regulatory clinical trial in India. Rule 25(v) of the New Drugs and Clinical Trials Rules, 2019 requires registration before the first subject is enrolled, and the same applies to bioavailability and bioequivalence studies. Many ethics committees, medical colleges and journals also require it for other studies, including postgraduate thesis research.

Can a trial be registered on the CTRI retrospectively?

No. Since 1 April 2018 the CTRI registers studies only prospectively, before the first participant is enrolled. A trial that has already started enrolment cannot be registered, even if it holds a REF number. Retrospective data collection studies must also be registered before data collection begins.

Who should register a trial on the CTRI, the sponsor or the investigator?

Either the principal investigator or the primary sponsor, as agreed between them. The CTRI holds the primary sponsor ultimately accountable for proper registration. In multi-centre or multi-sponsor trials the lead investigator or lead sponsor registers, and a company trial is registered under the company’s name rather than an employee’s account.

How long does CTRI registration take?

The CTRI reviews a submitted trial within 10 working days and returns it for clarifications or modifications, while sending verification emails to the trial contacts. The overall time then depends on how quickly the registrant makes the changes, uploads the approvals, obtains the confirmations and resubmits the trial.

Is there a fee for CTRI registration?

No. Registering a trial with the Clinical Trials Registry – India is free, and searching the registry is free. The costs to a sponsor lie in preparing the dataset and obtaining the ethics committee and regulatory approvals that must be uploaded before registration can be completed.

Does the CTRI issue a registration certificate?

No. The CTRI number itself is the proof of registration and is quoted wherever it is required. The registered record is publicly viewable on the CTRI website, and a PDF copy of the record can be generated from the listing and submitted to the authority asking for it.

About this guide

This guide is based on the CTRI’s published FAQ at ctri.nic.in, read on 4 November 2026, and on rule 25 of the New Drugs and Clinical Trials Rules, 2019. It was written by Sahithya K, and reviewed by Divya Chandradhara It states the position as at 4 November 2026 and is reviewed every six months.